ArisGlobal

ArisGlobal offers LifeSphere, a comprehensive cloud-based platform designed to support various aspects of drug development. This platform integrates a proprietary cognitive computing engine and employs advanced AI technologies, including dynamic data extraction and LLM-based narrative generation, to improve efficiency and accuracy in data handling. LifeSphere encompasses functionalities such as multivigilance, intake and triage, reporting and analytics, signal and risk management, and regulatory information management. ArisGlobal also leads the GenAI Council for Life Sciences, which promotes the use of generative AI technologies within the industry. The company serves a significant portion of the global market, including 80% of the top 50 biopharma companies, and is headquartered in the United States with additional offices in Europe, India, Japan, and China.